NCT06010732View on ClinicalTrials.gov

In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

February 22, 2024

Conditions
Caries
Interventions
DRUG

0 ppm F (placebo, negative control)

• Each subject will use this product during one of the three treatment periods in the crossover study design.

DRUG

1100 ppm F as sodium fluoride (positive control)

• Each subject will use this product during one of the three treatment periods in the crossover study design.

DRUG

1100 ppm F as sodium fluoride Test Product

• Each subject will use this product during one of the three treatment periods in the crossover study design.

Trial Locations (1)

46202

Indiana University School of dentistry, Oral Health Research institute 415 Lansing Street, Indianapolis

All Listed Sponsors
collaborator

HALEON

INDUSTRY

lead

Indiana University

OTHER

NCT06010732 - In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice | Biotech Hunter | Biotech Hunter